Cogent Biosciences, Inc. (COGT)
37.16
-0.30
(-0.80%)
USD |
NASDAQ |
Mar 06, 15:11
Cogent Biosciences Cash from Investing (Quarterly) : -322.77M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co., Inc. | -11.20B |
| Sarepta Therapeutics, Inc. | 96.21M |
| BridgeBio Pharma, Inc. | -13.75M |
| Olema Pharmaceuticals, Inc. | 17.27M |
| Revolution Medicines, Inc. | 74.88M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -79.10M |
| Cash from Financing (Quarterly) | 588.67M |
| Free Cash Flow | -266.00M |
| Free Cash Flow Per Share (Quarterly) | -0.5406 |
| Free Cash Flow to Equity (Quarterly) | -258.15M |
| Free Cash Flow to Firm (Quarterly) | -78.63M |
| Free Cash Flow Yield | -5.58% |